SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

ViaDerma Inc. (VDRM)

Add VDRM Price Alert      Hide Sticky   Hide Intro
Moderator: mick, balamidas, Helter Skelter, GoldenDD, stockdarockk, CMIH
Search This Board:
Last Post: 1/16/2017 2:42:28 AM - Followers: 251 - Board type: Free - Posts Today: 8


ViaDerma, Inc.

A Division of ViaDerma, Inc. , A Public Company.

Breakthrough Rapid Delivery of Nutrients and Medicines

ViaDerma, Inc. is a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to stem-cell therapy.

About Our Products


Proprietary and Trade Secret Mechanism of Action

ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.

The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.

This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.

The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.

Skin Layer Organization

A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.

The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.

Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.

In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.


We are developing products in the following fields of use;

Topical antibiotics

Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.

  • Estimated Global prevalence rate of all types of bacterial infection including pets: 2 Billion.
    Estimated Global prevalence rate of MRSA: 140 million.
Topical toenail antifungal

Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.

Anti-viral formula

Treats symptoms of Influenza which is a$4B/ year global market: Common

  • Estimated Global prevalence rate of Influenza: 355-1065 million.
    Estimated Global prevalence rate of “Bird Flu”: Very rare, about 500 cases.
    Estimated Global prevalence rate of “Swine Flu”: 1420 million were infected in 2009
Wound care

Diabetic foot wounds.

  • Diabetic foot Ulcers; $1.5B/year global market. 12 million people per year

Contact Details

ViaDerma's global headquarters is located at
8950 W. Olympic Blvd, Suite 576, Beverly Hills, CA 90211.

We are currently in discussions with companies in Australia & New Zealand, India, China, and West Africa.

Phone: 310.871.3996

Headlines Get Headlines for:

Tuesday, August 5, 2014

Tuesday, June 10, 2014

Older Headlines - Most Recent Headlines



Authorized Shares: 400,000,000 a/o Nov 10, 2016

Outstanding Shares: 200,319,103 a/o Nov 10, 2016

Float: 51,061,509 a/o June 30, 2016

Low Floaters Move Fast!

Par Value    0.001


$VDRM COULD BE THE pharmacy stock of the year. This stock could run 30,000% here's why.

1) EXTREMELY OVERSOLD and unknown 
2) ONLY 150 MILLION A\S! Makes it the TINIEST FLOAT VS PRICE out of ALL pharmacy stockso in the whole country!
3) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER. 
4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.
7) STRONG HANDS HOLDING 11 million shares out of the TINY 18 million float.
8) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.
9) THEY HAVE A PATENT which big boys have to be eyeing.


THIS IS NOT A REGULAR PENNY STOCK. The LOWEST FLOAT vs price vs ALL PHARMA STOCKS IN THE COUNTRY. BIG BOARD OR OTC LAND. ALL OF THEM. Pharma stocks have the HIGHIGHEST EST percentage gain in big boards or penny stocks




LOS ANGELES, CA--(Marketwired - November 14, 2016) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, announced today the Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases. The transdermal system can deliver through topical skin absorption to localized areas and directly into the blood stream. The Patent application using the combination of CBD's and THC with the delivery system was filed in 2014. The Patent Pending transdermal system can deliver medications and nutrients into the body through the skin. For example, a person with a migraine headache can place the CBD and THC combined with the delivery compound and apply to the neck with immediate absorption into the bloodstream through the corroded artery. ViaDerma, Inc. is also in the clinical testing stages of an anti-aging topical solution, topical pain medication, a topical for male-pattern baldness, and a topical designed to boost male libido.

On November 8th, medical and recreational marijuana was passed in several states that voted on medical marijuana provisions, in what is turning out to be, the biggest electoral victory for marijuana reform since 2012. The use of CBD's is known for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#6416  Sticky Note VDRM News! >> ViaDerma, Inc's CEO Files New Helter Skelter 01/12/17 10:09:33 AM
#5015  Sticky Note VDRM MUCH HIGHER $1.50 to $5.00 NEAR TERM 2dollarbill 11/26/16 07:11:25 PM
#3497  Sticky Note ViaDerma, Inc. Enters the (MMJ) or Medical balamidas 11/15/16 10:16:08 AM
#7073 casinoo 01/16/17 02:42:28 AM
#7072   VDRM WILL SMASH THROUGH .01+ ON TUESDAY, WE halbroke1 01/16/17 01:45:40 AM
#7071   Calm before the storm ;) BERKSHIRE AGENT 01/16/17 01:37:01 AM
#7070   BMs are up over 20 in the last nvidiaforgames 01/16/17 01:08:24 AM
#7069   Link please GOINGUP-AGAIN 01/16/17 12:56:17 AM
#7068   Hey what the hell is wrong with you. Zexcaliber 01/16/17 12:53:01 AM
#7067   Can you share any of you DD? I'm Wireman05 01/16/17 12:21:09 AM
#7066   That buy rating goes on like a neon kid biscuit 01/16/17 12:13:23 AM
#7064   Float here is getting locked down. Nearly PokerStar 01/15/17 11:54:42 PM
#7063   Look at the run up.... MM's tried Stocker1 01/15/17 11:29:19 PM
#7062   Shoulda, coulda, woulda, If I Stocker1 01/15/17 11:28:03 PM
#7061   VDRM Security Details presence 01/15/17 11:25:21 PM
#7060 Wireman05 01/15/17 11:23:54 PM
#7059   Https:// Wireman05 01/15/17 11:18:38 PM
#7058   100% agreed this is going to move big. sorc92 01/15/17 11:17:28 PM
#7057   yaboy520 does nothin but bash. Look at ddtburg 01/15/17 11:15:54 PM
#7056   Forget about the noise that shows up out PokerStar 01/15/17 11:15:34 PM
#7055   You don't have a clue: we have new sorc92 01/15/17 11:00:02 PM
#7054   Been looking in the mirror, hey. choctaw 01/15/17 10:39:31 PM
#7053   Short? I don't even know how to short yaboy520 01/15/17 10:37:49 PM
#7052   Dang troll. Doc_Mitch 01/15/17 10:30:22 PM
#7051   This one is going BIG. Plenty of PokerStar 01/15/17 10:28:48 PM
#7050   I've seen him on many boards. That's 1990 01/15/17 10:26:32 PM
#7049   That's not proof amigo. Your statement is simple Doc_Mitch 01/15/17 10:24:24 PM
#7048   STATISTICS HAVE PROVEN THAT 99% OF OTC PENNY yaboy520 01/15/17 10:22:53 PM
#7047   Why and/or how do you come to that conclusion? Doc_Mitch 01/15/17 10:21:12 PM
#7046   BEEN DOING DD ON THIS ALL WEEKEND, CONCLUSION...............SCAM yaboy520 01/15/17 10:20:05 PM
#7045   Love the low float and story here. Unbelievable BERKSHIRE AGENT 01/15/17 07:22:30 PM
#7044   Don't know about y'all but this long weekend t8rX 01/15/17 05:51:52 PM
#7043   I'm choosing to believe it stands for "victory Doc_Mitch 01/15/17 05:36:50 PM
#7042   Thanks onco 01/15/17 04:54:08 PM
#7041   You can find all you need know by Don 01/15/17 04:50:19 PM
#7040   Link to any DD on the R/S infoTIA onco 01/15/17 04:33:17 PM
#7039   Hey Doc...I'm feeling good about VDRM, except the BigBlackDog 01/15/17 04:23:26 PM
#7038   I hope your right! Go VDRM Doc_Mitch 01/15/17 03:44:31 PM
#7037   VDRM feeling like a smaller version of OWCP BERKSHIRE AGENT 01/15/17 03:39:06 PM
#7036   VDRM 0.0150 on tuesday . MARK THIS. 100% greatest_of_them_all 01/15/17 03:29:36 PM
#7035   Has management changed from the management where two presence 01/15/17 03:17:45 PM
#7034 casinoo 01/15/17 02:52:58 PM
#7033   Anybody that watched l2 Friday seen how easy Razor09 01/15/17 02:44:39 PM
#7032   Great ss here folks we could be in Razor09 01/15/17 02:42:45 PM
#7031   VDRM IS .10++, THERE IS NO STOPING IT...AND halbroke1 01/15/17 02:16:43 PM
#7030   No doubt bud, looking forward to it! BigJuan 01/15/17 02:15:46 PM
#7029   Agreed, this one will surprise many...... VDRM BigJuan 01/15/17 02:15:21 PM
#7028   Yup cool. Should be a good week here. MeLotsOfMoney 01/15/17 02:15:07 PM
#7027   I smell da boom here like .05 plus abazaba375 01/15/17 02:06:41 PM
#7026   Been around here before just don't post much. BigJuan 01/15/17 02:00:36 PM
#7025   If it does eow at .10 Then I MeLotsOfMoney 01/15/17 12:31:12 PM
#7024   Hope so too MeLotsOfMoney 01/15/17 12:28:48 PM